Sponsored by:

Nuclear Medicine: Page 360

PET/CT shows slight edge over MRI in melanoma staging
By Jonathan S. Batchelor
VIENNA - A recent prospective study comparing whole-body MRI with whole-body PET/CT in staging newly diagnosed malignant melanoma demonstrated that PET/CT has a slight edge in accuracy, but that both modalities missed local and distant metastases.
March 7, 2006
AuntMinnie.com Molecular Imaging Radiology Insider
By Jonathan S. Batchelor
March 5, 2006
SNM disburses technologist, physician grants
By AuntMinnie.com staff writers
The Society of Nuclear Medicine (SNM) recently awarded $58,000 in scholarships and grants for molecular/nuclear medicine technologist students.
February 27, 2006
Siemens, PETNet buy New England PETNet
By AuntMinnie.com staff writers
Siemens Medical Solutions and subsidiary PETNet Pharmaceuticals have purchased full ownership of the New England PETNet manufacturing and distribution center in Woburn, MA.
February 26, 2006
Schering, IBA ink radiopharma deal
By AuntMinnie.com staff writers
German contrast media firm Schering said that its French subsidiary, Schering S.A.S., will transfer the radiopharmaceutical business of CIS bio international to a consortium formed by Ion Beam Applications (IBA), of Louvain-la-Neuve, Belgium, and the Institut National des Radioéléments of Walloon, Belgium.
February 22, 2006
Therapeutic radiopharmaceutical market poised for takeoff
By AuntMinnie.com staff writers
Although U.S. sales of therapeutic radiopharmaceuticals totaled just $57 million in 2005, rapid growth is anticipated over the next five to six years. By 2012, therapeutic radiopharmaceutical product sales should reach $1.9 billion, with high growth continuing beyond that time, according to a recent study by market research firm Bio-Tech Systems.
February 20, 2006
Digirad posts flat revenues, loss in 2005
By AuntMinnie.com staff writers
Nuclear medicine vendor Digirad reported fourth-quarter revenues of $17.4 million, down 2.2% compared with the $17.8 million posted in the fourth quarter last year. For the period (end-December 31), the Poway, CA-based firm had a net loss of $2.8 million, compared with net income of $22,000 last year.
February 16, 2006
MDS Nordion, Molecular Insight Pharmaceuticals partner
By AuntMinnie.com staff writers
Radioisotope developer MDS Nordion and Molecular Insight Pharmaceuticals have signed a six-year renewable contract to manufacture and supply Zemiva, a molecular imaging pharmaceutical being developed for cardiac ischemia.
February 15, 2006
Imagin taps Oliverio
By AuntMinnie.com staff writers
PET and PET/CT imaging center developer Imagin Molecular has appointed Positron president Joseph Oliverio as CEO.
February 14, 2006
Positron opens Chinese joint venture
By AuntMinnie.com staff writers
PET vendor Positron of Houston has officially launched its joint venture with Neusoft Medical Systems of China.
February 12, 2006
Draxis shows 2005 revenue growth
By AuntMinnie.com staff writers
Canadian radiopharmaceutical developer Draxis Health reported solid gains in revenues and a slight dip in net income for its 2005 fiscal year (end-December 31).
February 9, 2006
Digirad partners with Ultrascan
By AuntMinnie.com staff writers
Nuclear medicine vendor Digirad has signed a personal services and management agreement with mobile ultrasound services provider Ultrascan of Suwanee, GA.
February 8, 2006
Previous Page
Page 360 of 437
Next Page